Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "placebo effect"

ResearchPUBMEDMay 1

The Placebo Effect in Rare Disease Clinical Trials: Measurement, Impact, and Statistical Approaches for Patient-as-Own-Control Designs.

Researchers studied whether the placebo effect (feeling better just because you expect to) is a real problem in rare disease trials where patients serve as their own comparison group. They found that for objective measurements like blood tests and imaging scans—which are used in most approved rare disease treatments—the placebo effect is very small and usually not a major concern.

WHY IT MATTERSIf you're considering enrolling in a rare disease trial using a patient-as-own-control design, this research shows that the results are likely measuring real treatment effects rather than just placebo effects, making the trial data more trustworthy for evaluating whether a treatment actually works.
Good to know

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases